Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eyenovia Inc (NQ: EYEN )

6.560 USD -0.010 (-0.15%)
Official Closing Price Updated: 7:07 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Eyenovia Inc

< Previous 1 2 3 4 5 6 7 Next >
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ONCS MOR Small Cap
From Benzinga
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DYN GNMK LLY
From Benzinga
Curt LaBelle, M.D. Appointed to Revelation Biosciences, Inc. Board of Directors
Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today... 
From Business Wire News Releases
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RDUS ALDX Earnings
From Benzinga
Eyenovia to Participate in Presbyopia Panel Discussion at the LifeSci Partners 10th Annual Corporate Access Event
From GlobeNewswire News Releases
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
Eyenovia has submitted an NDA to the FDA for MydCombi, a unique fixed combination mydriatic (pupil dilation) agent delivered by the Optejet dispenser. 
From Business Wire News Releases
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning ... 
Tags SEER IBB APRE
From Benzinga
Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopia
Eyenovia has enrolled its first patients in the Phase 3 VISION-1 Study of MicroLine for the improvement in near vision in patients with presbyopia. 
From Business Wire News Releases
Eyenovia Announces FDA Acceptance of IND for MicroLine for Presbyopia, Clearing Path to Initiate Phase 3 VISION Trial by Year End
Eyenovia obtains FDA acceptance of its IND application for MicroLine, a therapy designed for improvement in near vision in patients with presbyopia. 
From Business Wire News Releases
12 Healthcare Stocks Moving In Monday's After-Market Session
Gainers Altimmune (NASDAQ:ALT) shares increased by 8.87% to $10.06 during Monday's after-market session. This security traded at ... 
Tags ALT ADXS PAVM
From Benzinga
Eyenovia Reports Third Quarter 2020 Financial Results
Company to host conference call and webcast today, November 10, at 4:30pm ET 
From GlobeNewswire News Releases
The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VCEL BLFS DNLI
From Benzinga
Earnings Scheduled For November 10, 2020
Companies Reporting Before The Bell • Advance Auto Parts (NYSE:AAP) is projected to report quarterly earnings at $2.66 ... 
Tags VEC CXDO ISR
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags ONTX MRK SUPN
From Benzinga
Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10
Company to host an investor conference call and webcast at 4:30pm ET on that day 
From GlobeNewswire News Releases
11 Healthcare Stocks Moving In Monday's Pre-Market Session
Gainers BioSpecifics Technologies (NASDAQ:BSTC) shares increased by 43.6% to $87.63. The market value of their outstanding shares ... 
Tags NVIV VXRT BSTC
From Benzinga
33 Stocks Moving in Monday's Pre-Market Session
Gainers Midatech Pharma plc (NASDAQ: MTP) rose 34% to $2.68 in pre-market trading after the company disclosed headline results of ... 
Tags Penny Stocks Pre/Market Outlook Trading Ideas
From Benzinga
Tuesday 10/13 Insider Buying Report: EYEN, RVT
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. 
Tags Stocks
From Market News Video
Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million
From GlobeNewswire News Releases
12 Healthcare Stocks Moving In Monday's Pre-Market Session
Gainers Eyenovia (NASDAQ:EYEN) stock surged 13.56% to $3.85 during Monday's pre-market session. The company's market cap ... 
Tags Market News ATXI Markets
From Benzinga
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), Bausch + Lomb, its leading global eye health business, and Eyenovia, Inc., (NASDAQ: EYEN) ("Eyenovia"), a clinical stage ophthalmic... 
From PR Newswire
Implied IWC Analyst Target Price: $126
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags QGEN Benzinga CBAY
From Benzinga
Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual Meeting
Drs. Siddarth Rathi, April Jasper to present latest analyses and updates from Eyenovia's clinical studies at the American Academy of Optometry 2020 
From Business Wire News Releases
Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
From GlobeNewswire News Releases
Implied IWC Analyst Target Price: $125
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering
From GlobeNewswire News Releases
Eyenovia, Inc. Announces Closing of Offering of Common Stock
From GlobeNewswire News Releases
68 Biggest Movers From Yesterday
Gainers Blonder Tongue Laboratories, Inc. (NYSE: BDR) shares climbed 77.6% to close at $1.35 on Wednesday after dropping over 4% ... 
Tags EYEN KVHI Top Gainers
From Benzinga
54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blonder Tongue Laboratories, Inc. (NYSE: BDR) shares jumped 340.7% to $3.35 after dropping over 4% on Tuesday. Blonder ... 
Tags IRTC CREE LITB
From Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.